DLAT as a Cuproptosis Promoter and a Molecular Target of Elesclomol in Hepatocellular Carcinoma (2025)

[1]	CaoM , LuoX , WuK , et al.. Targeting lysosomes in human disease: from basic research to clinical applications. Signal Transduct Target Ther, 2021, 6(1): 379 CrossRefGoogle scholar

[2]	TsvetkovP , CoyS , PetrovaB , et al.. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science, 2022, 375(6586): 1254-1261 CrossRefGoogle scholar

[3]	LinS , YangH . Ovarian cancer risk according to circulating zinc and copper concentrations: A metaanalysis and Mendelian randomization study. Clin Nutr, 2021, 40(4): 2464-2468 CrossRefGoogle scholar

[4]	XiaoY , ChenDI , ZhangX , et al.. Molecular study on copper-mediated tumor proteasome inhibition and cell death. Int J Oncol, 2010, 37(1): 81-87

[5]	BlockhuysS , CelauroE , HildesjöC , et al.. Defining the human copper proteome and analysis of its expression variation in cancers. Metallomics, 2017, 9(2): 112-123 CrossRefGoogle scholar

[6]	IshidaS , AndreuxP , Poitry-YamateC , et al.. Bioavailable copper modulates oxidative phosphorylation and growth of tumors. Proc Natl Acad Sci USA, 2013, 110(48): 19507-19512 CrossRefGoogle scholar

[7]	GeEJ , BushAI , CasiniA , et al.. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer, 2022, 22(2): 102-113 CrossRefGoogle scholar

[8]	ZuoXL , ChenJM , ZhouX , et al.. Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res, 2006, 114(1–3): 41-53 CrossRefGoogle scholar

[9]	LutsenkoS . Human copper homeostasis: a network of interconnected pathways. Curr Opin Chem Biol, 2010, 14(2): 211-217 CrossRefGoogle scholar

[10]	JiangY , HuoZ , QiX , et al.. Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes. Nanomedicine (Lond), 2022, 17(5): 303-324 CrossRefGoogle scholar

[11]	VoliF , ValliE , LerraL , et al.. Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion. Cancer Res, 2020, 80(19): 4129-4144 CrossRefGoogle scholar

[12]	LiaoY , ZhaoJ , BulekK , et al.. Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis. Nat Commun, 2020, 11(1): 900 CrossRefGoogle scholar

[13]

Chan

Willis

Kornhauser

, et al.. Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases. Clin Cancer Res, 2017, 23(3): 666-676

CrossRefGoogle scholar

[14]	GupteA , MumperRJ . Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev, 2009, 35(1): 32-46 CrossRefGoogle scholar

[15]	YoshiiJ , YoshijiH , KuriyamaS , et al.. The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int J Cancer, 2001, 94(6): 768-773 CrossRefGoogle scholar

[16]	ChenD , CuiQC , YangH , et al.. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res, 2006, 66(21): 10425-10433 CrossRefGoogle scholar

[17]	KarginovaO , WeekleyCM , RaoulA , et al.. Inhibition of Copper Transport Induces Apoptosis in Triple-Negative Breast Cancer Cells and Suppresses Tumor Angiogenesis. Mol Cancer Ther, 2019, 18(5): 873-885 CrossRefGoogle scholar

[18]	SungH , FerlayJ , SiegelRL , et al.. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 2021, 71(3): 209-249 CrossRefGoogle scholar

[19]	LuoXY , WuKM , HeXX . Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets. J Exp Clin Cancer Res, 2021, 40(1): 172 CrossRefGoogle scholar

[20]	LvH , LiuX , ZengX , et al.. Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma. Front Pharmacol, 2022, 13: 930041 CrossRefGoogle scholar

[21]	ChenQ , WangY , YangL , et al.. PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming. J Exp Clin Cancer Res, 2022, 41(1): 229 CrossRefGoogle scholar

[22]	GohWQ , OwGS , KuznetsovVA , et al.. DLAT subunit of the pyruvate dehydrogenase complex is upregulated in gastric cancer-implications in cancer therapy. Am J Transl Res, 2015, 7(6): 1140-1151

[23]	StoneS , JiangP , DayananthP , et al.. Complex structure and regulation of the P16 (MTS1) locus. Cancer Res, 1995, 55(14): 2988-2994

[24]	SongW , RenJ , XiangR , et al.. Identification of pyroptosis-related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in colorectal cancer. Oncoimmunology, 2021, 10(1): 1987636 CrossRefGoogle scholar

[25]	KimY , KangJW , KangJ , et al.. Novel deep learning-based survival prediction for oral cancer by analyzing tumor-infiltrating lymphocyte profiles through CIBER-SORT. Oncoimmunology, 2021, 10(1): 1904573 CrossRefGoogle scholar

[26]

Wang

Dai

Shen

, et al.. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm. Front Immunol, 2022, 13: 843408

CrossRefGoogle scholar

[27]	TangZ , KangB , LiC , et al.. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res, 2019, 47(W1): W556-W560 CrossRefGoogle scholar

[28]	LiT , FanJ , WangB , et al.. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res, 2017, 77(21): e108-e110 CrossRefGoogle scholar

[29]	LiSR , BuLL , CaiL . Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway. Signal Transduct Target Ther, 2022, 7(1): 158 CrossRefGoogle scholar

[30]	BuccarelliM , D’AlessandrisQ , MatarreseP , et al.. Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth. J Exp Clin Cancer Res, 2021, 40(1): 228 CrossRefGoogle scholar

[31]	WangpaichitrM , WuC , YouM , et al.. N′,N′-Dimethyl-N′,N′-bis(phenylcarbonothioyl) Propanedihydrazide (Elesclomol) Selectively Kills Cisplatin Resistant Lung Cancer Cells through Reactive Oxygen Species (ROS). Cancers (Basel), 2009, 1(1): 23-38 CrossRefGoogle scholar

[32]	GaoW , HuangZ , DuanJ , et al.. Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A. Mol Oncol, 2021, 15(12): 3527-3544 CrossRefGoogle scholar

[33]

O’Day

Eggermont

Chiarion-Sileni

, et al.. Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. J Clin Oncol, 2013, 31(9): 1211-1218

CrossRefGoogle scholar

DLAT as a Cuproptosis Promoter and a Molecular Target of Elesclomol in Hepatocellular Carcinoma (2025)

References